Engineering Targeting Materials for Therapeutic Cancer Vaccines.

Briquez, Priscilla S; Hauert, Sylvie; de Titta, Alexandre; Gray, Laura T; Alpar, Aaron T; Swartz, Melody A; Hubbell, Jeffrey A

Briquez, Priscilla S; Hauert, Sylvie; de Titta, Alexandre; Gray, Laura T; Alpar, Aaron T; Swartz, Melody A; Hubbell, Jeffrey A.

Afiliação

Briquez PS; Pritzker School of Molecular Engineering, The University of Chicago, Chicago, IL, United States.
Hauert S; Pritzker School of Molecular Engineering, The University of Chicago, Chicago, IL, United States.
de Titta A; Agap2 Zürich, Zurich, Switzerland.
Gray LT; Pritzker School of Molecular Engineering, The University of Chicago, Chicago, IL, United States.
Alpar AT; Pritzker School of Molecular Engineering, The University of Chicago, Chicago, IL, United States.
Swartz MA; Pritzker School of Molecular Engineering, The University of Chicago, Chicago, IL, United States.
Hubbell JA; Ben May Department of Cancer Research, The University of Chicago, Chicago, IL, United States.

Front Bioeng Biotechnol ; 8: 19, 2020.

Article em En | MEDLINE | ID: mdl-32117911

Palavras-chave

cancer; immunoengineering; immunotherapy; material engineering; targeting strategies; vaccines

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Bioeng Biotechnol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google